To date, four trials have been completed, and two trials are ongoing
In a simpler, single-target peptide, an impurity might create background noise
The Precision Peptide Genetic Test reveals predispositions in GLP-1 and GIP receptor pathways, but it does not predict your exact medication response or guarantee specific side effect timelines
Older age, prior heart failure (HF) and CV events, peripheral artery disease, and kidney complications can identify a subgroup of patients with T2D at high risk of mortality who are likely to achieve the greatest benefit from aggressive management of modifiable risk factors and newer glucose-lowering agents
Because peptide therapy may affect different body systems, medical evaluation and ongoing provider guidance are important before and during treatment
Read Full Article: #DiabetesResearch #CinnamomumZeylanicum #MetabolicHealth #Cardiometabolic #PreclinicalStudy #Phytotherapy To view or add a comment, sign in New research by investigators at the UAB Comprehensive Diabetes Center demonstrates that TIXiMED's oral compound, #TIX100, effectively prevents weight rebound following discontinuation of GLP-1 treatment in a mouse model of diet-induced obesity